Rivaroxaban Dabigatran published presentations and documents on DocSlides.
Alexander T Cohen . On behalf of the MAGELLAN Ste...
(EINSTEIN CHOICE). Ryan Sparks, . PharmD. , BCPS....
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Rivaroxaban Plus Aspirin in Patients With and Wit...
Stabilized 1-7 Days Post-Index Event. Exclusions:...
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
EVI. dence. on . S. troke prevention . I. n pati...
Magnus Ohman MB, on behalf of the GEMINI-ACS-1 In...
Stratified by Baseline CV Risk Category. Aspirin ...
Dr. Phil Wells on behalf of the EINSTEIN CHOICE ...
A ssessment of D ual antiplatelet therapy versus...
“JIH. ” Hospital, Yogyakarta, Indonesia. The U...
R. ivaroxaban . I. n atrial . F. ibrillation patie...
Sonia Anand, on . behalf of the COMPASS Steering C...
rivaroxaban. group vs. 1.02% of the vitamin K ant...
VTE death. ) for . rivaroxaban. vs. . enoxaparin....
Kourosh. . Sadeghi. Tehran University of medical ...
Paul P. . Dobesh. , . Pharm.D. , FCCP, BCPS, BCCP....
G. . Turpie. Professor Emeritus of Medicine. McM...
Northlakes. Community Clinic. Minong, WI. Novel ...
Annelise Gallien, MD FRCPC. Moncton City Hospital...
How Do Real-World Data Fit In? . Program Goals. V...
A Look at New Oral Anticoagulants. Linda Wing, . ...
Fred V. Plapp MD PhD. Pathology and Laboratory Me...
, . BCPS, BCCCP. Associate Professor | Department...
Anticoagulation and Thrombosis Management A Revie...
Bleeding and cancer risk in patients with vascul...
This presentation is based on the . December 2013....
Provided by ProCE, LLC and supported by an educati...
M.A . Akbarzadeh. MD. Assistant . professor of . ...
hip fractures. Dr Linda Xu . linda.xu@health.nsw.g...
Clinical Associate Professor of Medicine. SSM Heal...
Mpiko. . Ntsekhe. , Bongani . Mayosi. * and Salim...
CrCl. : creatinine clearance, CTO: chronic total o...
1. Contact haematologist on call. , document DOAC ...
Copyright © 2025 DocSlides. All Rights Reserved